摘要
TNF-α是一种具有广泛生物学活性的前炎症细胞因子,参与哮喘整个病理生理过程。可溶性肿瘤坏死因子受体(sTNFR)可以拮抗肿瘤坏死因子活性,已被用来治疗与TNF相关的炎性疾病。将sTNFRI-IgGFc基因插入腺病毒穿梭质粒pDC316,与辅助质粒pBHGloxΔE1,3Cre共转染HEK293细胞,重组产生Ad-sTNFRI-IgGFc,PCR鉴定毒种正确后,进行扩增、纯化和滴度测定,转染人气道平滑肌细胞,利用RT-PCR、免疫组化方法,流式细胞仪,ELISA检测转染后细胞中sTNFRI-IgGFc的转录和表达。实验结果证明成功构建了Ad-sTNFRI-IgGFc腺病毒载体,感染性滴度达3×1010TCID50/mL,200moi转染气道平滑肌细胞阳性率达99.32%,转染后气道平滑肌细胞在mRNA和蛋白水平均有sTNFRI-IgGFc表达。转染上清稀释64倍后仍对TNF有拮抗活性。为将表达sTNFRI-IgGFc腺病毒基因治疗哮喘的实验研究提供了基础。
Tumour necrosis factor (TNF-α) is a pro-inflammatory cytokine that has been implicated in many aspects of the airway pathology in asthma, and which has recently been highlighted as potentially important in refractory asthma. To study the feasibility of local treatment of asthma with recombinant adenovirus vector carrying soluble extra-cellular region of TNF receptor I-IgGFc (sTNFRI-IgGFc) fusion protein, The sTNFRI-IgGFc gene was subcloned into the adenovirus shuttle plasmid pDC316, the products were co-transfected into HEK293 cell line with helper plasmid pBHGloxAEI,3Cre. The recombinant adenovirus (Ad-sTNFRI-IgGFc) was produced by homologous recombination of above 2 plasmids in HEK293 cells. After identification with PCR, Ad-sTNFRI- IgGFc was amplified and purified, its titer was measured by TCID50 assay. The transcription and expression of sTNFRI-IgGFc gene in rransfected human airway smooth muscle cells (HASMCs) was detected by RT-PCR, ELISA and immunological histochemistry.The anti-TNF activity assay of transfected HASMCs culture supernatant was measured by MTT. Ad-sTNFRI-IgGFc was successfully constructed with the titer of 3×10^10TCID50/mL. Ad-sTNFRI-IgGFc can transfect HASMC with high efficacy. The transcription of sTNFRI-IgGFc mRNA and the expression of protein were confirmed in the transfected HASMCs. Moreover, the product in 100μL expression supernatant could completely antagonize the cytolytic effect of 2ng TNFa on L929 cells, even at 1/64 dilution. This study forms the basement of the experiment study on local treatment of asthma with adenovirus expressing sTNFRI-IgGFc.
出处
《生物工程学报》
CAS
CSCD
北大核心
2008年第5期774-779,共6页
Chinese Journal of Biotechnology
基金
国家高技术研究发展计划(863)(No.2007AA02Z458)资助~~
关键词
可溶性肿瘤坏死因子受体
腺病毒载体
人气道平滑肌细胞
支气管哮喘
soluble tumor necrosis factor alpha receptor(sTNFR), adenovirus vector, human airway smooth muscle celIs(HASMCs), asthma